Author:
Mahittikorn Aongart,Kotepui Kwuntida Uthaisar,De Jesus Milanez Giovanni,Masangkay Frederick Ramirez,Kotepui Manas
Abstract
AbstractCo-infection with malaria and human immunodeficiency virus (HIV) increases the severity and mortality rates of both diseases. A better understanding of the effects of co-infections could help in the diagnosis, prompt treatment, prevention, and control of malarial parasites among HIV-infected patients. In this systematic review and meta-analysis, we estimated the prevalence and characteristics of severe malaria (SM) caused by co-infection with HIV. We included relevant studies that were conducted between the years 1991 and 2018 and reporting on SM. We pooled the prevalence of SM in patients with co-infection, pooled odds ratios of SM in patients with co-infection and Plasmodium mono-infection, and differences in laboratory parameters such as parasite density and leucocyte counts, between co-infected and Plasmodium mono-infected patients. The meta-analysis included 29 studies (1126 SM cases). The pooled prevalence of SM in co-infected patients using the data of 23 studies (SM = 795 cases, all co-infection cases = 2534 cases) was 43.0% (95% confidence interval [CI] 31.0–56.0%; I2, 98.0%). Overall, the odds of SM from 18 studies were pooled. The odds of SM were significantly higher in co-infected patients than in Plasmodium mono-infected patients (OR 2.41; 95% CI 1.43–4.08; I2 = 85%; P = 0.001) and also significantly higher in children (OR 9.69; 95% CI 5.14–18.3; I2, 0%; P < 0.0001; two studies) than in adults (OR 2.68; 95% CI 1.52–4.73; I2, 79.0%; P = 0.0007; 12 studies). Co-infected patients with SM had a higher parasite density than those with Plasmodium mono-infection when the data of seven studies were analysed (SMD, 1.25; 95% CI 0.14–2.36; I2, 98.0%; P = 0.03) and higher leukocyte counts when the data of four studies were analysed (MD, 1570 cells/µL; 95% CI 850–2300 cells/µL; I2, 21.0%; P < 0.0001). Thus, the prevalence of SM among patients co-infected with Plasmodium spp. and HIV is high. Because co-infections could lead to SM, patients with Plasmodium spp. and HIV co-infection should be identified and treated to reduce the prevalence of SM and the number of deaths.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. WHO. World Malaria Report 2019 (2019). https://www.who.int/publications-detail/world-malaria-report-2019. Accessed 25 July 2020.
2. Berg, A. et al. Increased severity and mortality in adults co-infected with malaria and HIV in Maputo, Mozambique: A prospective cross-sectional study. PLoS ONE 9, e88257. https://doi.org/10.1371/journal.pone.0088257 (2014).
3. WHO. Malaria in HIV/AIDS Patients (2017). http://www10.who.int/malaria/areas/high_risk_groups/hiv_aids_patients/en/. Accessed 25 July 2020.
4. WHO. (2019). HIV/AIDS. Available from https://www.who.int/news-room/fact-sheets/detail/hiv-aids Accessed 31 June 2020.
5. WHO. Severe malaria. Trop. Med. Int. Health 19, 7–131 (2014).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献